JP2023057209A - Non-aqueous oral composition - Google Patents
Non-aqueous oral composition Download PDFInfo
- Publication number
- JP2023057209A JP2023057209A JP2021166581A JP2021166581A JP2023057209A JP 2023057209 A JP2023057209 A JP 2023057209A JP 2021166581 A JP2021166581 A JP 2021166581A JP 2021166581 A JP2021166581 A JP 2021166581A JP 2023057209 A JP2023057209 A JP 2023057209A
- Authority
- JP
- Japan
- Prior art keywords
- component
- oral composition
- mass
- aqueous oral
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 59
- 102000004190 Enzymes Human genes 0.000 claims abstract description 34
- 108090000790 Enzymes Proteins 0.000 claims abstract description 32
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 claims abstract description 9
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 claims abstract description 8
- 239000002826 coolant Substances 0.000 claims abstract description 7
- FPJRGEOLQICYQZ-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(CC#N)C=C1 FPJRGEOLQICYQZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims abstract description 5
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930007503 menthone Natural products 0.000 claims abstract description 5
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 claims abstract description 4
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims abstract description 4
- 229940095045 isopulegol Drugs 0.000 claims abstract description 4
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 claims abstract description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims abstract description 4
- WXABJFUNSDXVNH-HYVNUMGLSA-N (1r,2s,5r)-5-methyl-2-propan-2-yl-n-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1C(=O)NCCC1=CC=CC=N1 WXABJFUNSDXVNH-HYVNUMGLSA-N 0.000 claims abstract description 3
- -1 glycerin fatty acid ester Chemical class 0.000 claims description 62
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 47
- 239000000194 fatty acid Substances 0.000 claims description 47
- 229930195729 fatty acid Natural products 0.000 claims description 47
- 229940088598 enzyme Drugs 0.000 claims description 32
- 235000011187 glycerol Nutrition 0.000 claims description 31
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 239000004365 Protease Substances 0.000 claims description 23
- 239000000551 dentifrice Substances 0.000 claims description 16
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 108090000417 Oxygenases Proteins 0.000 claims description 12
- 102000004020 Oxygenases Human genes 0.000 claims description 12
- 108010001682 Dextranase Proteins 0.000 claims description 11
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 150000005846 sugar alcohols Polymers 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000019419 proteases Nutrition 0.000 claims description 8
- 108090000526 Papain Proteins 0.000 claims description 7
- 239000002324 mouth wash Substances 0.000 claims description 7
- 229940051866 mouthwash Drugs 0.000 claims description 7
- 229940055729 papain Drugs 0.000 claims description 7
- 235000019834 papain Nutrition 0.000 claims description 7
- 239000004366 Glucose oxidase Substances 0.000 claims description 6
- 108010015776 Glucose oxidase Proteins 0.000 claims description 6
- 108010029541 Laccase Proteins 0.000 claims description 6
- 235000019420 glucose oxidase Nutrition 0.000 claims description 6
- 229940116332 glucose oxidase Drugs 0.000 claims description 6
- 108010004032 Bromelains Proteins 0.000 claims description 5
- 108010023244 Lactoperoxidase Proteins 0.000 claims description 5
- 102000045576 Lactoperoxidases Human genes 0.000 claims description 5
- 235000019835 bromelain Nutrition 0.000 claims description 5
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 claims description 5
- 229940057428 lactoperoxidase Drugs 0.000 claims description 5
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 claims description 4
- 108090000350 actinidain Proteins 0.000 claims description 4
- 229940105990 diglycerin Drugs 0.000 claims description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 4
- 229940086319 nattokinase Drugs 0.000 claims description 4
- 108010073682 nattokinase Proteins 0.000 claims description 4
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 229920001451 polypropylene glycol Polymers 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- FYNXOZOQSPWTPU-UHFFFAOYSA-N n,2,3-trimethyl-2-propan-2-ylbutan-1-amine Chemical compound CNCC(C)(C(C)C)C(C)C FYNXOZOQSPWTPU-UHFFFAOYSA-N 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 description 26
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
- 125000004432 carbon atom Chemical group C* 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 15
- 210000000214 mouth Anatomy 0.000 description 14
- 229960003237 betaine Drugs 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 11
- 239000000049 pigment Substances 0.000 description 11
- 239000000377 silicon dioxide Substances 0.000 description 10
- 239000000606 toothpaste Substances 0.000 description 10
- 229940034610 toothpaste Drugs 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 9
- 239000002280 amphoteric surfactant Substances 0.000 description 9
- 239000003945 anionic surfactant Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 8
- 235000019658 bitter taste Nutrition 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000002304 perfume Substances 0.000 description 7
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 6
- 108010031396 Catechol oxidase Proteins 0.000 description 6
- 102000030523 Catechol oxidase Human genes 0.000 description 6
- 239000003082 abrasive agent Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 6
- 229960002216 methylparaben Drugs 0.000 description 6
- 238000005498 polishing Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 229940085605 saccharin sodium Drugs 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 239000004711 α-olefin Substances 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 206010016334 Feeling hot Diseases 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 4
- 108010005843 Cysteine Proteases Proteins 0.000 description 3
- 102000005927 Cysteine Proteases Human genes 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 159000000001 potassium salts Chemical class 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 2
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 2
- WXABJFUNSDXVNH-UHFFFAOYSA-N 5-methyl-2-propan-2-yl-n-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NCCC1=CC=CC=N1 WXABJFUNSDXVNH-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010059378 Endopeptidases Proteins 0.000 description 2
- 102000005593 Endopeptidases Human genes 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical class CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002272 anti-calculus Effects 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- QYIXCDOBOSTCEI-FBVYSKEZSA-N epidihydrocholesterin Chemical compound C([C@@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-FBVYSKEZSA-N 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000001683 mentha spicata herb oil Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000019721 spearmint oil Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 229940095068 tetradecene Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 150000005691 triesters Chemical class 0.000 description 2
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical class CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- LBIZZGIYNNLXQN-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid Chemical compound CCCCCCCCCCCCOC(=O)CS(O)(=O)=O LBIZZGIYNNLXQN-UHFFFAOYSA-N 0.000 description 1
- 239000001837 2-hydroxy-3-methylcyclopent-2-en-1-one Substances 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- ILKFYYOGOCVZRU-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid Chemical class CCCCCCCCCCCC(=O)NCCC(O)=O ILKFYYOGOCVZRU-UHFFFAOYSA-N 0.000 description 1
- HKJKXDULJBGDED-UHFFFAOYSA-N 3-(tetradecylamino)propanoic acid Chemical class CCCCCCCCCCCCCCNCCC(O)=O HKJKXDULJBGDED-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical class CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- TWXUTZNBHUWMKJ-UHFFFAOYSA-N Allyl cyclohexylpropionate Chemical compound C=CCOC(=O)CCC1CCCCC1 TWXUTZNBHUWMKJ-UHFFFAOYSA-N 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 101000935015 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) N-acetyl-6-hydroxytryptophan oxidase ivoB Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical class CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- APTGPWJUOYMUCE-UHFFFAOYSA-N S-Ethyl thioacetate Chemical compound CCSC(C)=O APTGPWJUOYMUCE-UHFFFAOYSA-N 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000741781 Trametes sp. Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 description 1
- CEEYADXHYYFPDR-UHFFFAOYSA-N [methyl(tridecyl)amino] acetate Chemical compound CCCCCCCCCCCCCN(C)OC(C)=O CEEYADXHYYFPDR-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium phosphate dihydrate Substances O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical class CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical class C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000009627 gardenia yellow Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940070808 lauroyl aspartate Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229940070800 myristoyl glutamate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940100690 oral cream Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- AXCXHFKZHDEKTP-UHFFFAOYSA-N para-methoxycinnamaldehyde Natural products COC1=CC=C(C=CC=O)C=C1 AXCXHFKZHDEKTP-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、非水系口腔用組成物に関する。 The present invention relates to non-aqueous oral compositions.
歯磨剤の溶媒として、水に代えて非水溶媒を用いることで、溶媒の水和熱による温感実感を歯磨剤に付与することが可能である。このような非水系歯磨剤に、歯垢の分解・除去機能を有する酵素を配合することが行われている(例えば、特許文献1及び2)。 By using a non-aqueous solvent instead of water as a solvent for the dentifrice, it is possible to impart a warm sensation to the dentifrice due to the heat of hydration of the solvent. Such non-aqueous dentifrices are blended with enzymes capable of decomposing and removing dental plaque (for example, Patent Documents 1 and 2).
ここで、酵素を非水系歯磨剤に配合すると、非水系に特有の分散性の悪さから、磨きはじめにえぐみを感じることがあり、使用感が低下することがある。このような不利益を解消するため、冷感剤が配合されている。特許文献3には、酵素、アニオン界面活性剤を含む歯磨剤組成物に、ヒドロキシエチルセルロースジメチルジアリルアンモニウム塩と所定の香料組成物を配合することにより、酵素の口腔内滞留性を改善し、液分離を抑制できることが記載されている。特許文献4には、所定の数平均分子量を有するポリビニルピロリドン、所定のグリコール類、及び酵素を含有する非水系練歯磨剤が記載されている。特許文献4には、グルコースオキシダーゼ等の酵素と、ペパーミント油、スペアミント油等の矯味矯臭剤を含んでもよいことが記載されている。 Here, when an enzyme is added to a non-aqueous dentifrice, a harsh feeling may be felt at the beginning of brushing due to the poor dispersibility peculiar to a non-aqueous dentifrice, and the usability may be deteriorated. In order to eliminate such disadvantages, a cooling agent is added. In Patent Document 3, a dentifrice composition containing an enzyme and an anionic surfactant is blended with a hydroxyethyl cellulose dimethyl diallyl ammonium salt and a predetermined fragrance composition to improve the retention of the enzyme in the oral cavity and cause liquid separation. can be suppressed. Patent Document 4 describes a non-aqueous toothpaste containing polyvinylpyrrolidone having a prescribed number average molecular weight, prescribed glycols, and an enzyme. Patent Document 4 describes that enzymes such as glucose oxidase and flavoring agents such as peppermint oil and spearmint oil may be included.
しかしながら、特許文献3及び4のような従来技術では、酵素配合時のえぐみの発生を十分に抑制することが困難である。本発明の目的は、酵素を含む非水系口腔用組成物において、使用時のえぐみの発生の抑制又は緩和を実現することにある。 However, with conventional techniques such as those disclosed in Patent Documents 3 and 4, it is difficult to sufficiently suppress the occurrence of harshness when adding enzymes. An object of the present invention is to suppress or alleviate the occurrence of harshness during use in a non-aqueous oral cavity composition containing an enzyme.
本発明者らは下記の〔1〕~〔8〕を提供する。
〔1〕(A)成分:酵素、及び
(B)成分:N-エチル-p-メンタン-3-カルボキサミド、3-l-メントキシプロパン-1,2-ジオール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、(1R、2S、5R)-5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3カルボキサミド)酢酸エチル、2-イソプロピル-N、2,3-トリメチルブチルアミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、及び、メントングリセロールケタールからなる群より選ばれる少なくとも1種の冷感剤
を含有する非水系口腔用組成物。
〔2〕(C)成分:グリセリン脂肪酸エステルを更に含有する、〔1〕に記載の非水系口腔用組成物。
〔3〕(B)成分の含有量が0.0001~0.3質量%である、〔1〕又は〔2〕に記載の非水系口腔用組成物。
〔4〕(A)成分が、グルカナーゼ、オキシゲナーゼ、及びプロテアーゼ、からなる群より選ばれる少なくとも1種を含む、〔1〕~〔3〕のいずれか1項に記載の非水系口腔用組成物。
〔5〕グルカナーゼが、デキストラナーゼ、又はムタナーゼであること、
オキシゲナーゼが、ラッカーゼ、ラクトパーオキシダーゼ、又はグルコースオキシダーゼであること、及び、
プロテアーゼが、パパイン、アクチニジン、ブロメライン、又はナットウキナーゼであること
のいずれかを満たす、〔4〕に記載の非水系口腔用組成物。
〔6〕(D)成分:ポリエチレングリコール、グリセリン、ジグリセリン、プロピレングリコール、及びポリプロピレングリコールからなる群より選ばれる少なくとも1種の多価アルコールを更に含有する〔1〕~〔5〕のいずれか1項に記載の非水系口腔用組成物。
〔7〕(A)成分の酵素の酵素力価の、(B)成分の含有量に対する比率(A/B比)が、6,000~200,000,000単位/gである〔1〕~〔6〕のいずれか1項に記載の非水系口腔用組成物。
〔8〕歯磨剤、洗口剤、マウススプレー、口腔用保湿ジェル、クリーム又はクリームマウススプレーである、〔1〕~〔7〕のいずれか1項に記載の非水系口腔用組成物。
The present inventors provide the following [1] to [8].
[1] Component (A): Enzyme, and Component (B): N-ethyl-p-menthane-3-carboxamide, 3-l-menthoxypropane-1,2-diol, N-(4-cyanomethylphenyl )-p-menthanecarboxamide, (1R, 2S, 5R)-5-methyl-2-propan-2-yl-N-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide, 3-(p-menthane -3 carboxamide) at least one cooling agent selected from the group consisting of ethyl acetate, 2-isopropyl-N, 2,3-trimethylbutyramide, menthyl lactate, menthyl monosuccinate, isopulegol, and menthone glycerol ketal Non-aqueous oral composition containing.
[2] Component (C): The non-aqueous oral composition according to [1], further comprising a glycerin fatty acid ester.
[3] The non-aqueous oral composition according to [1] or [2], wherein the content of component (B) is 0.0001 to 0.3% by mass.
[4] The non-aqueous oral composition according to any one of [1] to [3], wherein component (A) contains at least one selected from the group consisting of glucanase, oxygenase, and protease.
[5] the glucanase is dextranase or mutanase;
the oxygenase is laccase, lactoperoxidase, or glucose oxidase; and
The non-aqueous oral composition according to [4], wherein the protease is papain, actinidin, bromelain, or nattokinase.
[6] Component (D): Any one of [1] to [5] further containing at least one polyhydric alcohol selected from the group consisting of polyethylene glycol, glycerin, diglycerin, propylene glycol, and polypropylene glycol The non-aqueous oral composition according to the item.
[7] The ratio of the enzyme titer of component (A) to the content of component (B) (A/B ratio) is 6,000 to 200,000,000 units/g [1]- The non-aqueous oral composition according to any one of [6].
[8] The non-aqueous oral composition according to any one of [1] to [7], which is a dentifrice, mouthwash, mouth spray, oral moisturizing gel, cream or cream mouth spray.
本発明によれば、酵素を含有するにも拘らず、使用時のえぐみの発生を抑制又は緩和できる、非水系口腔用組成物が提供される。 ADVANTAGE OF THE INVENTION According to this invention, the non-aqueous composition for oral cavity which can suppress or alleviate generation|occurrence|production of harshness at the time of use is provided in spite of containing an enzyme.
〔1.口腔用組成物〕
組成物は、下記の(A)及び(B)成分を含み、好ましくは(C)成分をさらに含む。
[1. Oral composition]
The composition contains the following components (A) and (B), and preferably further contains component (C).
〔(A)成分:酵素〕
(A)成分は、酵素である。
酵素は、通常、加水分解酵素(ヒドロラーゼ)、酸化還元酵素(オキシゲナーゼ)であり、中でも、口腔内においてう蝕の進行抑制、予防に関わる酵素(例えば、歯垢の分解、口臭の原因成分分解、ステインの除去)に関わる酵素が好ましい。このような加水分解酵素としては、例えば、グルカナーゼ、及びプロテアーゼが挙げられる。
[(A) component: enzyme]
The (A) component is an enzyme.
Enzymes are usually hydrolases and oxidoreductases (oxygenases). Among them, enzymes involved in the inhibition and prevention of caries progression in the oral cavity (e.g., decomposition of dental plaque, decomposition of causative components of bad breath, Enzymes involved in stain removal) are preferred. Such hydrolytic enzymes include, for example, glucanases and proteases.
-グルカナーゼ-
グルカナーゼは、グルカンのグリコシド結合の加水分解を触媒する酵素である。グルカナーゼの基質であるグルカンは、D-グルコースがグリコシド結合(例えば、α-1,3結合、α-1,4結合、α-1,6結合、β-1,3結合、β-1,4結合、β-1,6結合)で連結する構造を有するポリマー(二糖類以上の多糖類)である。グルカンとしては、例えば、α-グルカン(例えば、デキストラン、ムタン、プルラン、アミロペクチン、グリコーゲン、アミロース)、β-グルカン(例えば、セルロース、ラミナラン、カードラン、カロース)が挙げられる。グルカナーゼは、α-1,3結合及び/又はα-1,6結合を分解するグルカナーゼが好ましく、デキストラナーゼ、ムタナーゼがより好ましい。これにより、ストレプトコッカス・ミュータンスが生成するグルカンを分解し、口腔内の歯垢の分解及び除去を実現できる。グルカナーゼの由来は特に限定されず、微生物、植物、動物等の天然由来でもよいし、遺伝子組換え、化学合成等人工的に調製されたものでもよい。グルカナーゼがデキストラナーゼである場合、デキストラナーゼ生成能を有する細菌(例えば、ケトミウム属、ペニシリウム属、アスペルギルス属、スピカリア属、ラクトバチルス属、セルビブリオ属細菌)由来デキストラナーゼでもよい。グルカナーゼは、1種を単独で又は2種以上を組み合わせて使用してもよい。
-Glucanase-
Glucanases are enzymes that catalyze the hydrolysis of glycosidic bonds in glucans. Glucan, which is a substrate of glucanase, is composed of D-glucose bound by glycosidic bonds (e.g., α-1,3 bond, α-1,4 bond, α-1,6 bond, β-1,3 bond, β-1,4 bond). It is a polymer (polysaccharide of disaccharides or higher) having a structure linked by bonds, β-1,6 bonds). Glucans include, for example, α-glucans (eg, dextran, mutan, pullulan, amylopectin, glycogen, amylose), β-glucans (eg, cellulose, laminaran, curdlan, callose). The glucanase is preferably a glucanase that cleaves an α-1,3 bond and/or an α-1,6 bond, more preferably a dextranase or a mutanase. As a result, the glucan produced by Streptococcus mutans can be decomposed, and the decomposition and removal of dental plaque in the oral cavity can be realized. The origin of glucanase is not particularly limited, and it may be naturally derived from microorganisms, plants, animals, etc., or may be artificially prepared by genetic recombination, chemical synthesis, or the like. When the glucanase is dextranase, it may be derived from bacteria capable of producing dextranase (for example, bacteria belonging to the genera Chaetomium, Penicillium, Aspergillus, Spicaria, Lactobacillus, and Servibrio). Glucanase may be used singly or in combination of two or more.
-プロテアーゼ-
プロテアーゼは、タンパク質のペプチド結合の加水分解を触媒する酵素である。プロテアーゼは、エンドペプチダーゼ及びエキソペプチダーゼ(アミノペプチダーゼ、カルボキシペプチダーゼ)のいずれでもよいが、エンドペプチダーゼが好ましい。エンドプロテアーゼとしては、例えば、パパイン、ブロメライン、アクチニジン等のシステインプロテアーゼ、ナットウキナーゼ等のセリンプロテアーゼが挙げられ、システインプロテアーゼが好ましく、パパインがより好ましい。パパインは、単位質量あたりの活性が高く、比較的少量で口腔バイオフィルム除去効果を発揮できる。プロテアーゼの由来は特に限定されず、微生物、植物、動物等の天然由来でもよいし、遺伝子組換え、化学合成等人工的に調製されたものでもよい。天然由来の場合、純度は特に限定されず、プロテアーゼ以外の成分を含んでもよい(例えば、植物抽出物)。プロテアーゼがシステインプロテアーゼの場合、パパイア、パイナップル、キウイ等の植物由来であることが好ましいが、これらに限定されず、アスペルギルス属(Aspergillus属)やバシルス属(Bacillus属)等の微生物由来でもよい。プロテアーゼは、1種を単独で又は2種以上を組み合わせて使用してもよい。
-Protease-
Proteases are enzymes that catalyze the hydrolysis of peptide bonds in proteins. The protease may be either endopeptidase or exopeptidase (aminopeptidase, carboxypeptidase), but endopeptidase is preferred. Endoproteases include, for example, cysteine proteases such as papain, bromelain and actinidin, and serine proteases such as nattokinase. Cysteine proteases are preferred, and papain is more preferred. Papain has a high activity per unit mass, and a relatively small amount can exert an oral biofilm removal effect. The origin of the protease is not particularly limited, and it may be naturally derived from microorganisms, plants, animals, etc., or may be artificially prepared by genetic recombination, chemical synthesis, or the like. If it is naturally derived, its purity is not particularly limited, and it may contain components other than protease (eg, plant extract). When the protease is a cysteine protease, it is preferably derived from plants such as papaya, pineapple, and kiwi, but is not limited thereto, and may be derived from microorganisms such as Aspergillus and Bacillus. Proteases may be used singly or in combination of two or more.
-酸化還元酵素(オキシゲナーゼ)-
オキシゲナーゼは、酸化還元を触媒する酵素である。オキシゲナーゼとしては、例えば、ポリフェノールオキシダーゼ、グルコースオキシダーゼ、ラクトパーオキシダーゼが挙げられ、ポリフェノールオキシダーゼが好ましい。ポリフェノールオキシダーゼは、カテコール、チロシン、クロロゲン酸、ドーパ、ピロガロール等のフェノール系化合物を酸化するオキシダーゼである。ポリフェノールオキシダーゼとしては、例えば、ラッカーゼ、カテコールオキシダーゼ、モノフェノールオキシダーゼが挙げられ、ラッカーゼが好ましい。オキシゲナーゼの由来は特に限定されず、微生物、植物、動物等の天然由来でもよいし、遺伝子組換え、化学合成等人工的に調製されたものでもよい。天然由来の場合、純度は特に限定されず、オキシゲナーゼ以外の成分を含んでもよい(例えば、植物抽出物)。オキシゲナーゼがポリフェノールオキシダーゼの場合、白色腐朽菌(例えば、トレメテス属細菌)由来であることが好ましい。オキシゲナーゼは、1種を単独で又は2種以上を組み合わせて使用してもよい。
-Oxidoreductase (oxygenase)-
Oxygenases are enzymes that catalyze redox. Oxygenases include, for example, polyphenol oxidase, glucose oxidase, and lactoperoxidase, with polyphenol oxidase being preferred. Polyphenol oxidase is an oxidase that oxidizes phenol compounds such as catechol, tyrosine, chlorogenic acid, dopa and pyrogallol. Examples of polyphenol oxidase include laccase, catechol oxidase, and monophenol oxidase, with laccase being preferred. The origin of oxygenase is not particularly limited, and it may be naturally derived from microorganisms, plants, animals, etc., or may be artificially prepared by genetic recombination, chemical synthesis, or the like. If it is naturally derived, its purity is not particularly limited, and it may contain components other than oxygenase (eg, plant extract). When the oxygenase is a polyphenol oxidase, it is preferably derived from white rot fungi (eg, Tremetes spp.). You may use oxygenase individually by 1 type or in combination of 2 or more types.
-(A)成分の酵素力価-
(A)成分の酵素力価(2種以上の酵素の組み合わせの場合、各酵素の酵素力価)は、2単位/g以上が好ましく、10単位/g以上がより好ましい。これにより、歯垢をより効率的に分解及び除去できる。上限は、200単位/g以下が好ましく、50単位/g以下がより好ましい。これにより、使用時のえぐみの発生を抑制できる。従って、2~200単位/gが好ましく、10~50単位/gがより好ましい。
- Enzyme titer of component (A) -
The enzyme titer of component (A) (in the case of a combination of two or more enzymes, the enzyme titer of each enzyme) is preferably 2 units/g or more, more preferably 10 units/g or more. Thereby, plaque can be decomposed and removed more efficiently. The upper limit is preferably 200 units/g or less, more preferably 50 units/g or less. As a result, it is possible to suppress the occurrence of harshness during use. Therefore, it is preferably 2 to 200 units/g, more preferably 10 to 50 units/g.
酵素力価において、1単位とは、1964年国際生化学連合の「国際単位」の定義に基づき、「至適条件下で、試料1L中に、温度30℃で1分間に1μmolの基質を変化させることができる酵素量」である(https://www.jslm.org/committees/standard/standard_Q&A.pdf参照)。 In the enzymatic titer, 1 unit is based on the definition of "international unit" of the 1964 International Union of Biochemistry, "under optimal conditions, 1 μmol of substrate is changed in 1 minute at a temperature of 30 ° C. in 1 L of sample. The amount of enzyme that can be produced” (see https://www.jslm.org/committees/standard/standard_Q&A.pdf).
〔(B)成分:冷感剤〕
(B)成分は冷感剤である。(B)成分は、例えば、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3カルボキサミド)酢酸エチル、2-イソプロピル-N、2,3-トリメチルブチルアミド、これらから選ばれる2種以上の組み合わせである。これらのうち、N-エチル-p-メンタン-3-カルボキサミド、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、及び3-(p-メンタン-3カルボキサミド)酢酸エチルが好ましい。
[(B) component: cooling agent]
The component (B) is a cooling agent. Component (B) is, for example, N-ethyl-p-menthane-3-carboxamide, menthyl lactate, menthyl monosuccinate, isopulegol, menthone glycerol ketal, N-(4-cyanomethylphenyl)-p-menthanecarboxamide, 3 -l-menthoxypropane-1,2-diol, 5-methyl-2-propan-2-yl-N-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide, 3-(p-menthane-3 carboxamido) ethyl acetate, 2-isopropyl-N, 2,3-trimethylbutyramide, and a combination of two or more selected from these. Among these, N-ethyl-p-menthane-3-carboxamide, N-(4-cyanomethylphenyl)-p-menthanecarboxamide, 3-l-menthoxypropane-1,2-diol, 5-methyl-2 -propan-2-yl-N-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide and ethyl 3-(p-menthane-3carboxamido)acetate are preferred.
-(B)成分の含有量-
(B)成分の含有量は、組成物全量に対し、0.0001質量%以上が好ましく、0.001質量%以上がより好ましく、0.01質量%以上がさらに好ましい。これにより、使用時のえぐみの発生を抑制でき、良好な使用実感を実現できる。上限は、0.3質量%以下が好ましく、0.2質量%以下がより好ましい。これにより、苦味を抑え、良好な使用実感を実現することができる。従って、(B)成分の含有量は、0.0001~0.3質量%が好ましく、0.001~0.3質量%がより好ましく、0.01~0.2質量%がさらに好ましい。
- Content of component (B) -
The content of component (B) is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, and even more preferably 0.01% by mass or more, relative to the total amount of the composition. As a result, it is possible to suppress the occurrence of harshness during use, and to realize a good feeling of use. The upper limit is preferably 0.3% by mass or less, more preferably 0.2% by mass or less. As a result, the bitterness can be suppressed and a good feeling of use can be realized. Therefore, the content of component (B) is preferably 0.0001 to 0.3% by mass, more preferably 0.001 to 0.3% by mass, even more preferably 0.01 to 0.2% by mass.
〔A/B比〕
(A)及び(B)成分の含有量の比率(A/B比)は、(A)成分の酵素力価の、(B)成分の含有量に対する比率(単位/g)で表すことができ、好ましくは6,000単位/g以上、より好ましくは10,000単位/g以上であり、上限は、好ましくは200,000,000単位/g以下、より好ましくは500,000単位/g以下である。従って、A/B比は、好ましくは6,000~200,000,000単位/gより好ましくは10,000~500,000単位/gである。これにより、(A)成分の含有量を適切に調整でき、使用時のえぐみを改善できる。
[A/B ratio]
The ratio of the contents of components (A) and (B) (A/B ratio) can be expressed as the ratio (unit/g) of the enzyme titer of component (A) to the content of component (B). , preferably 6,000 units/g or more, more preferably 10,000 units/g or more, and the upper limit is preferably 200,000,000 units/g or less, more preferably 500,000 units/g or less. be. Accordingly, the A/B ratio is preferably between 6,000 and 200,000,000 units/g, more preferably between 10,000 and 500,000 units/g. As a result, the content of component (A) can be appropriately adjusted, and harshness during use can be improved.
〔(C)成分:グリセリン脂肪酸エステル〕
(C)成分は、グリセリン脂肪酸エステルである。グリセリン脂肪酸エステルは、モノエステル、ジエステル及びトリエステルのいずれでもよく、好ましくはグリセリン脂肪酸トリエステル(脂肪酸トリグリセリド)である。脂肪酸に由来する部分の炭素原子数は、好ましくは4~22、より好ましくは6~16、更に好ましくは6~12、更により好ましくは8~10である。脂肪酸は、不飽和及び飽和脂肪酸のいずれでもよく、分岐鎖脂肪酸、直鎖脂肪酸でもよく、例えば、カプロン酸、カプリル酸、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、オレイン酸、リノール酸が挙げられる。グリセリン脂肪酸ジエステル及びトリエステルを構成する脂肪酸成分は、それぞれ異なってもよいし、3種共通でもよい。グリセリン脂肪酸エステルは、単体で製剤に添加してもよいし、香料中の成分として存在してもよい。(C)成分は、1種単独又は2種以上の組み合わせでもよい。
[(C) component: glycerin fatty acid ester]
(C) Component is a glycerin fatty acid ester. The glycerin fatty acid ester may be monoester, diester or triester, preferably glycerin fatty acid triester (fatty acid triglyceride). The number of carbon atoms in the fatty acid-derived portion is preferably 4-22, more preferably 6-16, still more preferably 6-12, still more preferably 8-10. Fatty acids may be either unsaturated or saturated fatty acids, branched-chain fatty acids, or straight-chain fatty acids. Examples include caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, oleic acid, and linoleic acid. be done. The fatty acid components constituting the glycerin fatty acid diester and triester may be different from each other, or may be common to all three types. The glycerin fatty acid ester may be added to the preparation alone or may be present as a component in the perfume. Component (C) may be used alone or in combination of two or more.
-(C)成分の含有量-
(C)成分の含有量は、組成物全量に対し、0.001質量%以上が好ましく、0.01質量%以上がより好ましい。これにより、使用時えぐみの発生を抑制できる。上限は、3%以下が好ましく、2%以下がより好ましい。これにより、変色等の品質低下を抑制できる。従って、(C)成分の含有量は、0.001~3質量%が好ましく、0.01~2質量%がより好ましい。
- Content of component (C) -
The content of component (C) is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, relative to the total amount of the composition. As a result, it is possible to suppress the occurrence of harshness during use. The upper limit is preferably 3% or less, more preferably 2% or less. As a result, deterioration in quality such as discoloration can be suppressed. Therefore, the content of component (C) is preferably 0.001 to 3% by mass, more preferably 0.01 to 2% by mass.
〔(D)成分:多価アルコール〕
(D)成分は、多価アルコールである。(D)成分は、非水系口腔用組成物における溶媒の位置づけである。多価アルコールは、通常、水と接触した際に水和熱を発生する25℃で液体の多価アルコールである。このような多価アルコールとしては、例えば、ポリエチレングリコール、グリセリン、ジグリセリン、プロピレングリコール、ポリプロピレングリコール又はこれらの2種以上の組み合わせであり、ポリエチレングリコール、グリセリン、ジグリセリン、プロピレングリコールが好ましく、グリセリン、ポリエチレングリコール、ブチレングリコールがより好ましい。これにより、温感実感の立ち上がりが良くなり、口腔内の脱脂感を向上できる。
[(D) component: polyhydric alcohol]
(D) A component is a polyhydric alcohol. (D) Component is the position of the solvent in the non-aqueous oral composition. Polyhydric alcohols are typically liquid polyhydric alcohols at 25° C. that generate heat of hydration when in contact with water. Such polyhydric alcohols include, for example, polyethylene glycol, glycerin, diglycerin, propylene glycol, polypropylene glycol, or a combination of two or more thereof, preferably polyethylene glycol, glycerin, diglycerin, propylene glycol, glycerin, More preferred are polyethylene glycol and butylene glycol. As a result, the sensation of warmth is improved, and the degrease feeling in the oral cavity can be improved.
-グリセリン-
多価アルコールは、通常、苦味があるが、グリセリンは比較的苦味が少ない。そのため、(D)成分がグリセリンを少なくとも含むことにより、組成物の苦味を抑制できる。グリセリンの含有量は、(D)成分全体に対し、20質量%以上が好ましく、50質量%以上がより好ましい。これにより、組成物の外観が良好となり、適度な粘度に調整できる。上限は、100質量%以下であればよく、85質量%以下が好ましく、80質量%以下がより好ましい。これにより、(D)成分由来の苦味を抑制できる。従って、グリセリンの含有量は、(D)成分全体に対し、好ましくは20~100質量%、より好ましくは50~85質量%、更に好ましくは50~80質量%である。
-Glycerin-
Polyhydric alcohols usually have a bitter taste, but glycerin is relatively less bitter. Therefore, when the component (D) contains at least glycerin, the bitterness of the composition can be suppressed. The glycerin content is preferably 20% by mass or more, more preferably 50% by mass or more, relative to the entire component (D). As a result, the appearance of the composition is improved, and the viscosity can be adjusted to an appropriate level. The upper limit may be 100% by mass or less, preferably 85% by mass or less, and more preferably 80% by mass or less. Thereby, the bitterness derived from the component (D) can be suppressed. Therefore, the content of glycerin is preferably 20 to 100% by mass, more preferably 50 to 85% by mass, still more preferably 50 to 80% by mass, based on the total component (D).
-ポリエチレングリコールの平均分子量-
ポリエチレングリコールの平均分子量(医薬部外品原料規格2006記載の平均分子量、以下同様)は、190~630が好ましい。上記平均分子量のポリエチレングリコールは、温感実感に比較的強く寄与することから、温感実感の強度を高めることができる。このようなポリエチレングリコールとしては、例えば、ポリエチレングリコール200(平均分子量190~210)、ポリエチレングリコール400(平均分子量380~420)、ポリエチレングリコール600(平均分子量570~630)が挙げられる。
-Average molecular weight of polyethylene glycol-
The average molecular weight of polyethylene glycol (the average molecular weight described in Standards for Quasi-Drug Ingredients 2006, the same shall apply hereinafter) is preferably 190-630. Polyethylene glycol having the above-mentioned average molecular weight contributes relatively strongly to the sensation of warmth, so that the intensity of the sensation of warmth can be enhanced. Examples of such polyethylene glycol include polyethylene glycol 200 (average molecular weight 190-210), polyethylene glycol 400 (average molecular weight 380-420), and polyethylene glycol 600 (average molecular weight 570-630).
-ポリエチレングリコールの含有量-
ポリエチレングリコール(好ましくは、平均分子量190~630のポリエチレングリコール)の含有量は、組成物全量に対し、10質量%以上が好ましく、15質量%以上がより好ましい。これにより、ポリエチレングリコール由来の苦味の使用感への影響を抑制できる。上限は、30質量%以下が好ましい。従って、好ましくは10質量%以上、より好ましくは15~30質量%である。
-Polyethylene glycol content-
The content of polyethylene glycol (preferably polyethylene glycol having an average molecular weight of 190 to 630) is preferably 10% by mass or more, more preferably 15% by mass or more, based on the total amount of the composition. Thereby, the influence of the bitterness derived from polyethylene glycol on the feeling of use can be suppressed. The upper limit is preferably 30% by mass or less. Therefore, it is preferably 10% by mass or more, more preferably 15 to 30% by mass.
-(D)成分の好ましい態様-
(D)成分の好ましい態様としては、以下が挙げられる:
(1)グリセリン及び平均分子量190~630のポリエチレングリコールの併用系;及び
(2)グリセリン、平均分子量190~630のポリエチレングリコール、及びブチレングリコールの併用系。
これらのうち、(1)が好ましく、(1)においてグリセリンの含有量が成分(D)全量の50%以上、好ましくは50~85%である態様がより好ましい。
-Preferred embodiment of component (D)-
Preferred embodiments of component (D) include the following:
(1) combination system of glycerin and polyethylene glycol having an average molecular weight of 190-630; and (2) combination system of glycerin, polyethylene glycol having an average molecular weight of 190-630 and butylene glycol.
Among these, (1) is preferable, and in (1), the content of glycerin is 50% or more, preferably 50 to 85%, of the total amount of component (D) is more preferable.
-(D)成分の含有量-
(D)成分の含有量は、組成物全量に対し通常、20質量%以上、好ましくは40質量%以上である。これにより、組成物の外観の劣化を抑制できる。組成物の全量に対し、上限は、通常、90質量%以下、好ましくは85質量%以下、より好ましくは80質量%以下である。これにより、粘度の過剰な低下を抑制し、良好な使用感を保持できる。従って、(D)成分の含有量は、通常20~90質量%、好ましくは20~85質量%、より好ましくは40~80質量%である。
- Content of component (D) -
The content of component (D) is generally 20% by mass or more, preferably 40% by mass or more, relative to the total amount of the composition. Thereby, deterioration of the appearance of the composition can be suppressed. The upper limit is usually 90% by mass or less, preferably 85% by mass or less, more preferably 80% by mass or less, relative to the total amount of the composition. As a result, an excessive decrease in viscosity can be suppressed, and a good feeling of use can be maintained. Accordingly, the content of component (D) is generally 20 to 90% by mass, preferably 20 to 85% by mass, more preferably 40 to 80% by mass.
〔非水系〕
組成物は、非水系口腔用組成物である。本明細書において非水系とは、実質的に水分を含まないことを意味し、口腔用組成物の製造工程において、水が意図的に加えられていないこと、原料中の水のみを含むことが好ましい。非水系口腔用組成物における水分量は、通常、2質量%以下、好ましくは1質量%以下、より好ましくは0.5質量%以下である。口腔用組成物の水分量は、配合前の原料に含まれる水分量の合計の全原料に対する割合(質量%)として、または、口腔用組成物の乾燥後重量と乾燥前重量との差分の乾燥前重量に対する割合(質量%)として、算出できる。
[Non-aqueous]
The composition is a non-aqueous oral composition. As used herein, the term "non-aqueous system" means substantially free of water. preferable. The water content in the non-aqueous oral composition is usually 2% by mass or less, preferably 1% by mass or less, and more preferably 0.5% by mass or less. The water content of the oral composition is the ratio (% by mass) of the total water content contained in the raw materials before blending to the total raw materials, or the difference between the dry weight and the dry weight of the oral composition. It can be calculated as a ratio (% by mass) to the original weight.
〔粘度〕
組成物の粘度(25℃)は、20~100Pa・sが好ましく、30~90Pa・sがより好ましく、35~80Pa・sがさらに好ましく、35~70Pa・sがさらにより好ましく、40~60Pa・sがとりわけ好ましい。粘度は、東機産業(株)(形式:VISCOMETER TVB-10)、ローターNo.6または7を使用して、回転数20rpm、測定時間3分間、25℃の条件で測定した場合の測定値である。
〔viscosity〕
The viscosity (25° C.) of the composition is preferably 20 to 100 Pa·s, more preferably 30 to 90 Pa·s, still more preferably 35 to 80 Pa·s, still more preferably 35 to 70 Pa·s, and 40 to 60 Pa·s. s is particularly preferred. Toki Sangyo Co., Ltd. (model: VISCOMETER TVB-10), rotor No. 6 or 7, and measured at 20 rpm for 3 minutes at 25°C.
〔任意成分〕
組成物は、本発明の効果を損なわない範囲で、(A)~(D)成分以外の他の成分を含有してもよい。他の成分としては、例えば、界面活性剤、甘味剤、香料、湿潤剤、粘結剤、研磨剤、pH調整剤、防腐剤、薬用成分、油性成分、着色剤(色素)等の口腔用組成物に配合され得る成分が挙げられるが、これらに限定されない。
[Optional component]
The composition may contain other components other than the components (A) to (D) as long as the effects of the present invention are not impaired. Other ingredients include, for example, surfactants, sweeteners, flavors, wetting agents, binders, abrasives, pH adjusters, preservatives, medicinal ingredients, oily ingredients, colorants (pigments), and other oral compositions. Ingredients that can be incorporated into the product include, but are not limited to.
-界面活性剤-
界面活性剤としては、例えば、アニオン界面活性剤、両性界面活性剤、ノニオン界面活性剤が挙げられ、温感の立ち上がりをより改善できるため、アニオン界面活性剤、両性界面活性剤が好ましく、アニオン界面活性剤がより好ましい。
-Surfactant-
Examples of surfactants include anionic surfactants, amphoteric surfactants, and nonionic surfactants. Anionic surfactants and amphoteric surfactants are preferred because they can further improve the rising of the warm feeling. Activators are more preferred.
アニオン界面活性剤としては、例えば、アルキル硫酸塩、アシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20、好ましくは12~18、より好ましくは14~16である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩が更に好ましい。 Anionic surfactants include, for example, alkyl sulfates, acyl amino acid salts, acyl taurine salts, α-olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfate, and lauryl sulfoacetate. Alkyl groups and acyl groups may be linear or branched, saturated or unsaturated, and usually have 10 to 20 carbon atoms, preferably 12 to 18 carbon atoms, and more preferably 14 to 16 carbon atoms. Salts may be selected from pharmacologically acceptable salts. Pharmaceutically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salts, potassium salts, calcium salts, magnesium salts and ammonium salts; organic base salts such as triethylammonium salts, triethanolammonium salts, pyridinium salts and diisopropylammonium salts; arginine salts and the like. and basic amino acid salts of Among them, inorganic base salts are preferred, alkali metal salts (eg, sodium salts, potassium salts) or ammonium salts are more preferred, and sodium salts are even more preferred.
アルキル硫酸塩としては、例えば、ラウリル硫酸塩、ミリストイル硫酸塩が挙げられる。アシルアミノ酸塩としては、例えば、ラウロイルサルコシン塩、ミリストイルサルコシン塩等のアシルサルコシン塩;ラウロイルグルタミン酸塩、ミリストイルグルタミン酸塩、パルミトイルグルタミン酸塩等のアシルグルタミン酸塩;N-ラウロイル-N-メチルグリシン塩、ココイルグリシン塩等のアシルグリシン塩;N-ラウロイル-β-アラニン塩、N-ミリスチル-β-アラニン塩、N-ココイル-β-アラニン塩、N-ラウロイル-N-メチル-β-アラニン塩、N-ミリストイル-N-メチル-β-アラニン塩、N-メチル-N-アシルアラニン塩等のアシルアラニン塩;ラウロイルアスパラギン酸塩等のアシルアスパラギン酸塩が挙げられる。アシルタウリン塩としては、例えば、ラウロイルメチルタウリン塩、N-メチル-N-アシルタウリン塩、N-ココイルメチルタウリン塩が挙げられる。α-オレフィンスルホン酸塩としては、テトラデセンスルホン酸塩(炭素原子数14~16のα-オレフィンスルホン酸)等の炭素原子数12~18のα-オレフィンスルホン酸塩が挙げられる。アニオン界面活性剤の他の例としては、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムが挙げられる。 Alkyl sulfates include, for example, lauryl sulfate and myristoyl sulfate. Acyl amino acid salts include, for example, acyl sarcosine salts such as lauroyl sarcosine salt and myristoyl sarcosine salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycinate and cocoylglycine. Acylglycine salts such as salts; N-lauroyl-β-alanine salt, N-myristyl-β-alanine salt, N-cocoyl-β-alanine salt, N-lauroyl-N-methyl-β-alanine salt, N-myristoyl acylalanine salts such as -N-methyl-β-alanine salts and N-methyl-N-acylalanine salts; and acyl aspartates such as lauroyl aspartate. Acyl taurine salts include, for example, lauroyl methyl taurine salts, N-methyl-N-acyl taurine salts, and N-cocoyl methyl taurine salts. The α-olefin sulfonate includes α-olefin sulfonates having 12 to 18 carbon atoms such as tetradecene sulfonate (α-olefin sulfonic acid having 14 to 16 carbon atoms). Other examples of anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
アニオン界面活性剤としては、α-オレフィンスルホン酸塩が好ましく、テトラデセンスルホン酸塩(炭素原子数14~16のα-オレフィンスルホン酸)がより好ましい。アニオン界面活性剤は、1種でもよいし、2種以上の組み合わせでもよい。 As the anionic surfactant, an α-olefin sulfonate is preferable, and a tetradecene sulfonate (α-olefin sulfonic acid having 14 to 16 carbon atoms) is more preferable. Anionic surfactants may be used alone or in combination of two or more.
アニオン界面活性剤を含む場合の含有量は、組成物全体の0.1質量%以上が好ましく、0.5質量%以上がより好ましい。これにより、使用時に口腔内での製剤の分散性が改善し、温感実感の立ち上がりが良好になる。上限は、3質量%以下が好ましく、2質量%以下がより好ましい。これにより、使用後の口腔内の脱脂感を低減させることができる。従って、組成物全体の0.1~3質量%が好ましく、0.5~2質量%がより好ましい。 When the anionic surfactant is included, the content thereof is preferably 0.1% by mass or more, more preferably 0.5% by mass or more, based on the total composition. As a result, the dispersibility of the preparation in the oral cavity is improved during use, and the warm feeling is improved. The upper limit is preferably 3% by mass or less, more preferably 2% by mass or less. This can reduce the feeling of degreasing in the oral cavity after use. Therefore, it is preferably 0.1 to 3% by mass, more preferably 0.5 to 2% by mass of the total composition.
両性界面活性剤としては、例えば、ベタイン型、アミノ酸型が挙げられ、ベタイン型が好ましい。ベタイン型両性界面活性剤としては、例えば、脂肪酸アミドプロピルベタイン(例えば、ヤシ油脂肪酸アミドプロピルベタイン)、アルキル酢酸ベタイン(例えば、ラウリルジメチルアミノ酢酸ベタイン等のアルキルアミノ酢酸ベタイン)、アルキルイミダゾリニウムベタイン(例えば、アルキルカルボキシメチルヒドロキシエチルイミダゾリニウムベタイン)が挙げられ、脂肪酸アミドプロピルベタイン、アルキル酢酸ベタインが好ましく、ヤシ油脂肪酸アミドプロピルベタインがより好ましい。両性界面活性剤がアルキル基、アシル基を有する場合、それらは直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20、好ましくは12~18、より好ましくは14~16である。両性界面活性剤は、純分(ベタイン純分)65%以上の溶液又は粉末であることが好ましい。これにより、組成物の水分の調整が容易となり得る。 Examples of amphoteric surfactants include betaine type and amino acid type, with betaine type being preferred. Examples of betaine-type amphoteric surfactants include fatty acid amidopropyl betaine (eg, coconut oil fatty acid amidopropyl betaine), alkyl acetate betaine (eg, alkyl amino acetate betaine such as lauryldimethylamino acetate betaine), and alkylimidazolinium betaine. (eg, alkylcarboxymethylhydroxyethylimidazolinium betaines), fatty acid amidopropylbetaines and alkylacetate betaines are preferred, and coconut oil fatty acid amidopropylbetaines are more preferred. When the amphoteric surfactant has an alkyl group or an acyl group, they may be linear or branched, saturated or unsaturated, and usually have 10 to 20 carbon atoms, preferably 12 to 18 carbon atoms. , more preferably 14-16. The amphoteric surfactant is preferably a solution or powder with a pure content (betaine pure content) of 65% or more. This can facilitate adjustment of the moisture content of the composition.
両性界面活性剤としては、脂肪酸アミドアルキルベタインが好ましく、ヤシ油脂肪酸アミドプロピルベタイン等の脂肪酸アミドプロピルベタインがより好ましい。両性界面活性剤は、1種でもよいし、2種以上の組み合わせでもよい。 As the amphoteric surfactant, fatty acid amidoalkyl betaine is preferable, and fatty acid amidopropyl betaine such as coconut oil fatty acid amidopropyl betaine is more preferable. Amphoteric surfactants may be used alone or in combination of two or more.
両性界面活性剤を含む場合の含有量は、組成物全体の0.1質量%以上が好ましく、0.3質量%以上がより好ましい。これにより、口腔内の脱脂感が十分に改善し、かつ温感実感の立ち上がりが向上する。上限は、3質量%以下が好ましく、2質量%以下がより好ましい。これにより、苦味が抑制され、味の良い使用感を十分に維持できる。従って、0.1~3質量%が好ましく、0.3~2質量%がより好ましい。 When the amphoteric surfactant is included, the content thereof is preferably 0.1% by mass or more, more preferably 0.3% by mass or more, based on the total composition. As a result, the feeling of degreasing in the oral cavity is sufficiently improved, and the rise of the feeling of warmth is improved. The upper limit is preferably 3% by mass or less, more preferably 2% by mass or less. As a result, the bitterness is suppressed, and the pleasant feeling of use can be sufficiently maintained. Therefore, 0.1 to 3% by mass is preferable, and 0.3 to 2% by mass is more preferable.
ノニオン界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル(例、ポリオキシエチレンソルビタンモノステアレート)、アルキロールアミド、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンアルケニルエーテル、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル(例、マルトース脂肪酸エステル)、糖アルコール脂肪酸エステル(例、マルチトール脂肪酸エステル、ラクチトール脂肪酸エステル)、脂肪酸ジエタノールアミド(例、ラウリル酸モノ又はジエタノールアミド)、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンポリオキシプロピレン脂肪酸エステル、ポリオキシエチレンポリオキシプロピレン(EOPO)コポリマー、アルキルグルコシド、脂肪酸ポリグリセリルが挙げられる。ポリオキシエチレンアルキルエーテルのアルキル基の炭素原子数は、通常12~18、好ましくは14~18であり(例えば、ラウリル、ステアリル基)、エチレンオキサイド平均付加モル数は、通常5~30モル、好ましくは15~30モルである。ポリオキシエチレン硬化ヒマシ油のエチレンオキサイド平均付加モル数は、通常5~100モル、好ましくは20~100モル、より好ましくは20~60モルである。ソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常12~18である。ポリオキシエチレンソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常16~18であり、エチレンオキサイド平均付加モル数は、通常10~40モルである。アルキロールアミドのアルキル鎖の炭素原子数は、通常12~14である。ポリオキシエチレンポリオキシプロピレン(EOPO)コポリマーは、エチレンオキサイドの平均付加モル数20~210、プロピレンオキサイドの平均付加モル数15~60のものが好ましく、ブロックコポリマーでもランダムコポリマーでもよい。 Examples of nonionic surfactants include polyoxyethylene alkyl ethers, polyoxyethylene hydrogenated castor oils, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters (e.g., polyoxyethylene sorbitan monostearate), alkylolamides, polyoxyethylene Ethylene fatty acid ester, polyoxyethylene alkenyl ether, glycerin fatty acid ester, sucrose fatty acid ester (eg, maltose fatty acid ester), sugar alcohol fatty acid ester (eg, maltitol fatty acid ester, lactitol fatty acid ester), fatty acid diethanolamide (eg, lauryl) acid mono- or diethanolamide), polyoxyethylene polyoxypropylene copolymers, polyoxyethylene polyoxypropylene fatty acid esters, polyoxyethylene polyoxypropylene (EOPO) copolymers, alkyl glucosides, fatty acid polyglyceryls. The number of carbon atoms in the alkyl group of the polyoxyethylene alkyl ether is generally 12 to 18, preferably 14 to 18 (eg, lauryl and stearyl groups), and the average number of added moles of ethylene oxide is generally 5 to 30 mol, preferably is 15-30 mol. The average mole number of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is generally 5 to 100 mol, preferably 20 to 100 mol, more preferably 20 to 60 mol. The number of carbon atoms in the fatty acid of the sorbitan fatty acid ester is usually 12-18. The number of carbon atoms in the fatty acid of the polyoxyethylene sorbitan fatty acid ester is generally 16-18, and the average number of moles of ethylene oxide added is generally 10-40 mol. The alkyl chain of the alkylolamide usually has 12-14 carbon atoms. The polyoxyethylene-polyoxypropylene (EOPO) copolymer preferably has an average added mole number of ethylene oxide of 20 to 210 and an average added mole number of propylene oxide of 15 to 60, and may be a block copolymer or a random copolymer.
ノニオン界面活性剤を含む場合の含有量は、組成物全体の0.05質量%以上が好ましく、0.5質量%以上がより好ましい。これにより、口腔内の脱脂感の改善が良好となる。上限は、2質量%以下が好ましく、1質量%以下がより好ましい。これにより、苦味を抑制でき、味の良い使用感を十分に維持できる。従って、0.05~2質量%が好ましく、より好ましくは0.5~1質量%である。 The content of the nonionic surfactant is preferably 0.05% by mass or more, more preferably 0.5% by mass or more, based on the total composition. As a result, the feeling of degreasing in the oral cavity can be improved. The upper limit is preferably 2% by mass or less, more preferably 1% by mass or less. As a result, the bitterness can be suppressed, and the pleasant feeling of use can be sufficiently maintained. Therefore, it is preferably 0.05 to 2% by mass, more preferably 0.5 to 1% by mass.
-甘味剤-
甘味剤としては、例えば、キシリトール、エリスリトール、マルチトール、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、グリチルリチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル、p-メトキシシンナミックアルデヒド等が挙げられる。甘味剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-sweetener-
Sweeteners include, for example, xylitol, erythritol, maltitol, saccharin, saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, glycyrrhizin, thaumatin, asparatylphenylalanine methyl ester, p- methoxycinnamic aldehyde and the like. A sweetener may be used individually by 1 type, and may be used in combination of 2 or more type.
-香料-
香料は、ペパーミント油、スペアミント油、アニス油、ユーカリ油、ウィンターグリーン油、カシア油、クローブ油、タイム油、セージ油、レモン油、オレンジ油、ハッカ油、カルダモン油、コリアンダー油、マンダリン油、ライム油、ラベンダー油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、マジョラム油、ベイ油、レモングラス油、オリガナム油、パインニードル油、ネロリ油、ローズ油、ジャスミン油、イリスコンクリート、アブソリュートペパーミント、アブソリュートローズ、オレンジフラワー等の天然香料及び、これら天然香料の加工処理(前溜部カット、後溜部カット、分留、液液抽出、エッセンス化、粉末香料化等)した香料、及び、メントール、カルボン、アネトール、シネオール、サリチル酸メチル、シンナミックアルデヒド、オイゲノール、チモール、リナロール、リナリールアセテート、リモネン、メントン、メンチルアセテート、N-置換-パラメンタン-3-カルボキサミド、ピネン、オクチルアルデヒド、シトラール、プレゴン、カルビールアセテート、アニスアルデヒド、エチルアセテート、エチルブチレート、アリルシクロヘキサンプロピオネート、メチルアンスラニレート、エチルメチルフェニルグリシデート、バニリン、ウンデカラクトン、ヘキサナール、プロピルアルコール、ブタノール、イソアミルアルコール、ヘキセノール、ジメチルサルファイド、シクロテン、フルフラール、トリメチルピラジン、エチルラクテート、メチルラクテート、エチルチオアセテート等の単品香料、更に、ストロベリーフレーバー、アップルフレーバー、バナナフレーバー、パイナップルフレーバー、グレープフレーバー、マンゴーフレーバー、バターフレーバー、ミルクフレーバー、フルーツミックスフレーバー、トロピカルフルーツフレーバー等の調合香料等、口腔用組成物に用いられる公知の香料素材を使用することができる。香料は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Perfume-
Peppermint oil, spearmint oil, anise oil, eucalyptus oil, wintergreen oil, cassia oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, peppermint oil, cardamom oil, coriander oil, mandarin oil, lime. Oil, Lavender Oil, Rosemary Oil, Laurel Oil, Chamomile Oil, Caraway Oil, Marjoram Oil, Bay Oil, Lemongrass Oil, Origanum Oil, Pine Needle Oil, Neroli Oil, Rose Oil, Jasmine Oil, Iris Concrete, Absolute Peppermint , absolute rose, orange flower, etc., and processed (pre-reservoir cut, post-reservoir cut, fractional distillation, liquid-liquid extraction, essence, powder perfume, etc.) processing of these natural perfumes, and menthol , carvone, anethole, cineole, methyl salicylate, cinnamic aldehyde, eugenol, thymol, linalool, linalyl acetate, limonene, menthone, menthyl acetate, N-substituted-paramenthane-3-carboxamide, pinene, octylaldehyde, citral, pulegone, Carbyl Acetate, Anisaldehyde, Ethyl Acetate, Ethyl Butyrate, Allylcyclohexane Propionate, Methyl Anthranilate, Ethyl Methyl Phenyl Glycidate, Vanillin, Undecalactone, Hexanal, Propyl Alcohol, Butanol, Isoamyl Alcohol, Hexenol, Dimethyl Sulfide, Cyclotene, Furfural, Trimethylpyrazine, Ethyllactate, Methyllactate, Ethylthioacetate, etc., Strawberry Flavor, Apple Flavor, Banana Flavor, Pineapple Flavor, Grape Flavor, Mango Flavor, Butter Flavor, Milk Flavor, Fruit Mixed flavors, tropical fruit flavors, and other mixed flavors can be used. Perfume may be used individually by 1 type, and may be used in combination of 2 or more type.
上記の香料素材は、組成物中に0.000001~1質量%使用することが好ましく、上記香料素材を使用した賦香用香料は、組成物中に0.1~2.0質量%使用するのがよい。 It is preferable to use 0.000001 to 1% by mass of the above perfume material in the composition, and 0.1 to 2.0% by mass of the perfume for perfuming using the above perfume material is used in the composition. It's good.
-湿潤剤-
湿潤剤としては、(D)成分として例示された多価アルコール以外の多価アルコールが好ましく、例えば、ソルビトール(ソルビット)等の糖アルコール;エチレングリコール等のグリコール;還元でんぷん糖化物が挙げられる。湿潤剤は1種でもよいし、2種以上の組み合わせでもよい。平均分子量は、医薬部外品原料規格2006記載の平均分子量である。
湿潤剤の含有量は、通常、0~20質量%、好ましくは1~10質量%である。
-wetting agent-
As the humectant, polyhydric alcohols other than the polyhydric alcohols exemplified as component (D) are preferred, and examples thereof include sugar alcohols such as sorbitol (sorbitol); glycols such as ethylene glycol; and reduced starch saccharification products. One type of wetting agent may be used, or two or more types may be used in combination. The average molecular weight is the average molecular weight described in the Standards for Quasi-drug Ingredients 2006.
The content of the wetting agent is usually 0-20% by weight, preferably 1-10% by weight.
-粘結剤-
粘結剤は、水溶性高分子等の有機粘結剤、無機粘結剤を使用できる。有機粘結剤としては、例えば、セルロース系粘結剤(例えば、カルボキシメチルセルロース(CMC)、そのナトリウム塩、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系粘結剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム)、合成水溶性高分子(例、(架橋型)ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルアルコール、アルギン酸プロピレングリコール)が挙げられる。無機粘結剤は、沈降性シリカ、火成性シリカ、ゲル化性シリカ、ゲル化性アルミニウムシリカ等の増粘性シリカ、ビーガム、ラポナイト、ベントナイト等の粘土鉱物などが挙げられ、好ましくは有機粘結剤であり、より好ましくはセルロース系粘結剤、他の多糖系粘結剤、合成水溶性高分子であり、更に好ましくは、カルボキシメチルセルロースナトリウム、カラギーナン、カルボキシビニルポリマーである。粘結剤は1種でもよいし、2種以上の組み合わせでもよい。
粘結剤の含有量は、組成物全体の0.1~3質量%が好ましく、0.1~2質量%がより好ましい。
-Binder-
As the binder, an organic binder such as a water-soluble polymer or an inorganic binder can be used. Organic binders include, for example, cellulose-based binders (e.g., carboxymethylcellulose (CMC), sodium salts thereof, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, cationized cellulose, etc.), and other polysaccharides. Binders (e.g., xanthan gum, guar gum, gellan gum, tragacanth gum, karaya gum, gum arabic, locust bean gum, carrageenan, sodium alginate), synthetic water-soluble polymers (e.g., (cross-linked) sodium polyacrylate, carboxyvinyl polymer, polyvinyl alcohol, propylene glycol alginate). Examples of the inorganic binder include thickening silica such as precipitated silica, igneous silica, gelling silica, and gelling aluminum silica; and clay minerals such as Veegum, laponite, and bentonite. More preferred are cellulose-based binders, other polysaccharide-based binders, and synthetic water-soluble polymers, and still more preferred are sodium carboxymethylcellulose, carrageenan, and carboxyvinyl polymer. 1 type of caking agents may be sufficient and 2 or more types of combinations may be sufficient as them.
The content of the binder is preferably 0.1 to 3% by mass, more preferably 0.1 to 2% by mass, based on the total composition.
-研磨剤-
研磨剤としては、例えば、無機研磨剤及び有機研磨剤のいずれでもよい。無機研磨剤としては、例えば、アルミノシリケート、ジルコノシリケート、結晶性ジルコニウムシリケート、チタン結合性シリカ等の研磨性シリカ;第2リン酸カルシウム・2水和塩又は無水和物、第1リン酸カルシウム、第3リン酸カルシウム、ピロリン酸カルシウム等のリン酸カルシウム系化合物;炭酸カルシウム等の炭酸カルシウム系研磨剤;水酸化カルシウム、硫酸カルシウム等の、炭酸/リン酸以外のカルシウム系研磨剤;酸化アルミニウム、水酸化アルミニウム、アルミナ等のアルミニウム系材料;無水ケイ酸、ゼオライト、ケイ酸ジルコニウム等のケイ酸系材料;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム系材料;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト系材料;二酸化チタン、雲母チタン、酸化チタン等のチタン系材料;ベントナイト等の鉱物が挙げられる。有機研磨剤としては、例えば、ポリメチルメタアクリレート、合成樹脂系研磨剤が挙げられる。これらのうち、研磨性シリカ、リン酸カルシウム系化合物が好ましく、研磨性シリカがより好ましい。研磨剤は1種でもよいし、2種以上の組み合わせでもよい。
研磨剤の配合量は、通常、組成物全体の0~70質量%、好ましくは2~30質量%である。
-Abrasive-
The abrasive may be, for example, either an inorganic abrasive or an organic abrasive. Examples of inorganic abrasives include abrasive silica such as aluminosilicate, zirconosilicate, crystalline zirconium silicate, and titanium-bonded silica; dicalcium phosphate dihydrate or anhydrate, monocalcium phosphate, and tricalcium phosphate. Calcium phosphate-based compounds such as calcium pyrophosphate; Calcium carbonate-based abrasives such as calcium carbonate; Calcium-based abrasives other than carbonate/phosphoric acid, such as calcium hydroxide and calcium sulfate; Aluminum oxide, aluminum hydroxide, alumina and the like Silicic acid-based materials such as silicic anhydride, zeolite, and zirconium silicate; Magnesium-based materials such as magnesium carbonate and trimagnesium phosphate; Apatite-based materials such as hydroxyapatite, fluoroapatite, and calcium-deficient apatite; Titanium dioxide , mica titanium, titanium oxide and other titanium-based materials; and bentonite and other minerals. Examples of organic abrasives include polymethyl methacrylate and synthetic resin abrasives. Among these, abrasive silica and calcium phosphate compounds are preferable, and abrasive silica is more preferable. One type of abrasive may be used, or two or more types may be used in combination.
The compounding amount of the abrasive is usually 0 to 70% by mass, preferably 2 to 30% by mass, based on the total composition.
-pH調整剤-
pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、カリウム塩、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム、水酸化カリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。pH調整剤の含有量は、通常、添加後の組成物のpHが5~9、好ましくは6~8.5になる量である。本明細書において、pH値は、通常、測定開始から25℃、3分後の値であり、東亜電波工業社製のpHメーター(型番Hm-30S)を用いて測定できる。
-pH adjuster-
Examples of pH adjusters include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid, and lactic acid, salts thereof, inorganic acids such as phosphoric acid (orthophosphoric acid), and salts thereof. (for example, potassium salt, sodium salt and ammonium salt), sodium hydroxide, potassium hydroxide and the like. Examples of inorganic acid salts include disodium hydrogen phosphate and sodium dihydrogen phosphate. The content of the pH adjuster is usually such that the pH of the composition after addition is 5 to 9, preferably 6 to 8.5. In this specification, the pH value is generally the value after 3 minutes at 25° C. from the start of measurement, and can be measured using a pH meter (Model Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
-防腐剤-
防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
-Preservative-
Examples of antiseptics include paraoxybenzoic acid esters (eg, methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, butyl parahydroxybenzoate), sodium benzoate, and the like. The preservatives may be used singly or in combination of two or more.
-薬用成分-
薬用成分としては、例えば、非イオン性殺菌剤(例、イソプロピルメチルフェノール)、カチオン性殺菌剤(例、塩化セチルピリジニウム、塩化ベンゼトニウム、塩化ベンザルコニウム)、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、ヒノキチオール、塩化リゾチーム、クロルヘキシジン塩類、トリクロロカルバニリド等の殺菌又は抗菌剤;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン類(例、アラントイン、アラントインクロルヒドロキシアルミニウム)、トラネキサム酸、アズレン、ジヒドロコレステロール、α-ビサボロール、グリチルリチン、グリチルレチン酸、ベルベリン、エピジヒドロコレステリン等の抗炎症剤;亜鉛、銅塩、スズ塩等の金属塩;正リン酸のカリウム塩、ナトリウム塩等の水溶性リン酸化合物;グリセロホスフェート等のキレート性リン酸化合物;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸dl-α-トコフェロール等の酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化ナトリウム等の収斂剤;銅クロロフィル、グルコン酸銅等の銅化合物;歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類;トウキ軟エキス、オウバクエキス、カミツレ、チョウジ、ローズマリー、オウゴン、ベニバナ、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドン、ヒドロキサム酸及びその誘導体、トリポリリン酸塩、メトキシエチレン無水マレイン酸共重合体、塩化ナトリウム、クロロフィル、サンギナリン抽出物、ベルベリン、ヒドロキサム酸及びその誘導体、ピロリン酸塩、ゼオライト、エピジヒドロコレステリン、トリクロロカルバニリド、クエン酸亜鉛を挙げることができる。薬用成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬用成分の含有量は、本発明の効果を妨げない範囲で常法に従って有効量を適宜設定できる。
-Medicinal Ingredients-
Examples of medicinal ingredients include nonionic fungicides (eg, isopropylmethylphenol), cationic fungicides (eg, cetylpyridinium chloride, benzethonium chloride, benzalkonium chloride), zinc gluconate, zinc citrate, triclosan, Bactericidal or antibacterial agents such as hinokitiol, lysozyme chloride, chlorhexidine salts, trichlorocarbanilide; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantoins (e.g., allantoin, allantoin) aluminum chlorohydroxyl), tranexamic acid, azulene, dihydrocholesterol, α-bisabolol, glycyrrhizin, glycyrrhetinic acid, berberine, anti-inflammatory agents such as epidihydrocholesterin; metal salts such as zinc, copper salts, tin salts; water-soluble phosphate compounds such as potassium salts and sodium salts; chelating phosphate compounds such as glycerophosphate; anticalculus agents such as condensed phosphates and ethanehydroxydiphosphonate; vitamin E (e.g., dl-α-acetic acid Blood flow promoters such as tocopherol acetate); hypersensitivity inhibitors such as potassium nitrate, aluminum lactate, strontium chloride; coating agents such as hydroxyethylcellulose dimethyldiallylammonium chloride; vitamin C (e.g., ascorbic acid or its salt), astringents such as sodium chloride; copper compounds such as copper chlorophyll and copper gluconate; anticalculus agents, amino acids such as alanine, glycine, proline; Plant extracts such as thyme, scutellaria root, clove, hamamelis; calopeptide, polyvinylpyrrolidone, hydroxamic acid and its derivatives, tripolyphosphate, methoxyethylene maleic anhydride copolymer, sodium chloride, chlorophyll, sanguinarine extract, berberine, hydroxamic acid and Mention may be made of its derivatives, pyrophosphates, zeolites, epidihydrocholesterin, trichlorocarbanilides, zinc citrate. A medicinal ingredient may be used individually by 1 type, and may be used in combination of 2 or more type. The content of the medicinal ingredient can be appropriately set to an effective amount according to a conventional method within a range that does not impair the effects of the present invention.
-油性成分-
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス、カルナバワックス、ライスワックス、ロジン等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ひまし油、やし油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。
- Oily component -
Examples of oily components include hydrocarbons such as squalane, liquid paraffin, petrolatum, microcrystalline wax, carnauba wax, rice wax, and rosin; higher alcohols (such as lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, iso Alcohols with 8 to 22 carbon atoms such as stearyl alcohol); higher fatty acids (for example, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), olive oil, castor oil, coconut oil, etc. and fatty acid esters such as isopropyl myristate.
-着色剤-
着色剤としては例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素や、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号、青色4号等の法定色素、リボフラビン、銅クロロフィリンナトリウム等が挙げられる。
非水系口腔用組成物が着色剤を含む際、その含有量は、非水系口腔用組成物の全体に対し0.00001~3質量%とすることが好ましい。
-coloring agent-
Examples of coloring agents include natural pigments such as safflower red pigment, gardenia yellow pigment, gardenia blue pigment, perilla pigment, monascus pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, tamarind pigment, Legal pigments such as Red No. 2, Red No. 3, Red No. 104, Red No. 105, Red No. 106, Red No. 227, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1, Blue No. 4, riboflavin, Copper chlorophyllin sodium etc. are mentioned.
When the non-aqueous oral composition contains a coloring agent, the content thereof is preferably 0.00001 to 3% by mass based on the total non-aqueous oral composition.
組成物は、練歯磨剤、ジェル状歯磨剤、液状歯磨剤、液体歯磨剤、粉歯磨剤等の歯磨剤、口腔用保湿ジェル、口腔用クリーム等の口腔用塗布剤、マウススプレー、洗口剤として利用でき、好ましくは練歯磨剤である。 The composition includes dentifrices such as toothpaste, gel-like dentifrice, liquid dentifrice, liquid dentifrice, and toothpaste, oral coating agents such as oral moisturizing gel and oral cream, mouth spray, and mouthwash. as a toothpaste, preferably a toothpaste.
組成物の剤形は、利用形態に応じて適宜選択することができ、特に限定されない。剤形としては、例えば、ゲル状、ペースト状、液状が挙げられる。 The dosage form of the composition can be appropriately selected according to the usage form, and is not particularly limited. Dosage forms include, for example, gels, pastes, and liquids.
〔2.組成物の製造方法〕
組成物の製造方法は特に限定されず、剤形に応じて、それぞれの通常の方法で調製され得る。例えば練歯磨剤として利用する場合、溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて脱泡(例えば、減圧等)を行う方法が挙げられる。得られる練歯磨は、容器に収容して製品とすることができる。容器は、形状、材質は特に制限されず、通常の練歯磨剤組成物に使用される容器を使用でき、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック容器等が挙げられる。
[2. Method for manufacturing the composition]
The method for producing the composition is not particularly limited, and it can be prepared by a conventional method depending on the dosage form. For example, when it is used as a toothpaste, a method of preparing components that dissolve in a solvent, mixing other insoluble components, and degassing (for example, reducing pressure, etc.) as necessary. The obtained toothpaste can be stored in a container to be used as a product. The shape and material of the container are not particularly limited, and containers commonly used for toothpaste compositions can be used. Examples thereof include plastic containers such as polyethylene, polypropylene, polyethylene terephthalate, and nylon.
以下、実施例及び比較例を示して本発明を具体的に説明するが、本発明は下記実施例に制限されるものではない。なお、表中の%は特に断らない限り質量%を示す。 EXAMPLES The present invention will be specifically described below with reference to examples and comparative examples, but the present invention is not limited to the following examples. In addition, % in the table indicates % by mass unless otherwise specified.
[実施例及び比較例に使用した主な原料]
(A-1)デキストラナーゼ:第一三共プロファーマ社製、13,000単位(unit)/g
(A-2)ラッカーゼ:天野エンザイム社製、「ラッカーゼダイワ」(白色腐朽菌(Trametes sp.)由来)
(A-3)パパイン:三菱化学フーズ社製、「精製パパイン」
(A-4)ムタナーゼ:天野エンザイム(株)製、「ムタナーゼ」
(A-5)ラクトパーオキシダーゼ:Sigma-Aldrich社製、「ラクトペルオキシダーゼ from bovine milk」
(A-6)グルコースオキシダーゼ:Sigma-Aldrich社製、「グルコースオキシダーゼ from Aspergillus niger」
(A-7)アクチニジン:ビーエイチエヌ株式会社製、「ザクティナーゼ(登録商標)」
(A-8)ブロメライン:合同酒精株式会社製、「ブロメライン」
(A-9)ナットウキナーゼ:株式会社日本生物科学研究所製、「納豆菌培養エキスNSK-SD」
(B-1)N-エチル-p-メンタン-3-カルボキサミド:ジボダン社製、「WS-3」
(B-2)N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド:ジボダン社製、「エバークール(登録商標)G-180」
(B-3)3-l-メントキシプロパン-1,2-ジオール:高砂香料工業株式会社製、「CA-10」
(C)脂肪酸トリグリセリド:不二製油株式会社、「中鎖脂肪酸トリグリセライド」
(D-1)濃グリセリン:阪本薬品工業株式会社製、「化粧品用濃グリセリン(99.5%)」
(D-2)ポリエチレングリコール400:三洋化成工業(株)製、「ポリエチレングリコール400」
CMC(カルボキシメチルセルロースナトリウム):ダイセルファインケム(株)製、「CMC1260」
SDS(ドデシル硫酸ナトリウム):富士フィルム和光純薬株式会社製、「sodium dodecyl sulfate」
シリカ:Solvay社製、「Tixosil(登録商標)73」
その他の成分については医薬部外品原料規格2006に適合したものを用いた。
[Main raw materials used in Examples and Comparative Examples]
(A-1) Dextranase: Daiichi Sankyo Propharma Co., Ltd., 13,000 units / g
(A-2) Laccase: Amano Enzyme Co., Ltd., "Laccase Daiwa" (derived from white rot fungus (Trametes sp.))
(A-3) Papain: Mitsubishi Kagaku Foods Co., Ltd., "purified papain"
(A-4) Mutanase: Amano Enzyme Co., Ltd., "Mutanase"
(A-5) Lactoperoxidase: Sigma-Aldrich, "lactoperoxidase from bovine milk"
(A-6) glucose oxidase: manufactured by Sigma-Aldrich, "glucose oxidase from Aspergillus niger"
(A-7) actinidin: manufactured by BNH Co., Ltd., "Zactinase (registered trademark)"
(A-8) Bromelain: “Bromelain” manufactured by Godo Shusei Co., Ltd.
(A-9) Nattokinase: "Natto bacteria culture extract NSK-SD" manufactured by Japan Biological Science Laboratory Co., Ltd.
(B-1) N-ethyl-p-menthane-3-carboxamide: "WS-3" manufactured by Givaudan
(B-2) N-(4-cyanomethylphenyl)-p-menthanecarboxamide: manufactured by Givaudan, "Evercool (registered trademark) G-180"
(B-3) 3-l-menthoxypropane-1,2-diol: manufactured by Takasago International Corporation, "CA-10"
(C) fatty acid triglyceride: Fuji Oil Co., Ltd., "medium chain fatty acid triglyceride"
(D-1) Concentrated glycerin: Sakamoto Pharmaceutical Co., Ltd., "Concentrated glycerin for cosmetics (99.5%)"
(D-2) Polyethylene glycol 400: manufactured by Sanyo Chemical Industries, Ltd., "Polyethylene glycol 400"
CMC (sodium carboxymethylcellulose): "CMC1260" manufactured by Daicel Finechem Co., Ltd.
SDS (sodium dodecyl sulfate): manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., "sodium dodecyl sulfate"
Silica: "Tixosil (registered trademark) 73" manufactured by Solvay
For other ingredients, those conforming to the Standards for Quasi-drug Ingredients 2006 were used.
実施例1~35及び比較例1~2(練歯磨剤)
下記調製方法に従って、練歯磨剤を調製した。各例の配合組成を表1~6に示す。組成物の水分量を、配合前の原料に含まれる水分量の合計の全原料に対する割合(質量%)として算出したところ、いずれも2質量%以下であった。なお、各組成における酵素製剤の使用量は、100gとした。
Examples 1-35 and Comparative Examples 1-2 (toothpaste)
A toothpaste was prepared according to the following preparation method. The formulation composition of each example is shown in Tables 1-6. When the water content of the composition was calculated as the ratio (% by mass) of the total water content contained in the raw materials before blending to the total raw materials, it was 2% by mass or less. The amount of enzyme preparation used in each composition was 100 g.
[歯磨剤組成物の調製方法]
原料を常法により配合し、1.5Lニーダー(石山工作所社製)を用い常温で混合し、減圧(圧力4kPa)による脱泡を行い、歯磨剤組成物を得た。
[Method for preparing dentifrice composition]
Raw materials were blended by a conventional method, mixed at room temperature using a 1.5 L kneader (manufactured by Ishiyama Kosakusho Co., Ltd.), and degassed under reduced pressure (pressure 4 kPa) to obtain a dentifrice composition.
得られた歯磨剤組成物を下記の手順で評価した。 The obtained dentifrice composition was evaluated by the following procedures.
[評価方法]
-磨き初めのえぐみの評価-
歯磨剤組成物1gを歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン社製)に乗せ、通常の方法でブラッシングしたときの、磨き初めのえぐみを、下記に示す評点基準によって、4段階で評価した。試験者7名の平均点を算出し、次の評価基準に従って、★、◎、○、△、×で表に示した。
[Evaluation method]
-Evaluation of sharpness at the beginning of polishing-
When 1 g of the dentifrice composition is placed on a toothbrush (clinica advantage toothbrush, 4-row compact normal, manufactured by Lion Corporation) and brushed in the usual manner, the harshness at the beginning of brushing is evaluated in 4 stages according to the following rating criteria. evaluated. The average score of the 7 testers was calculated and shown in the table as *, .circleincircle., .smallcircle., .DELTA.
(評点基準)
4点:磨き初めのえぐみを全く感じない
3点:磨き初めのえぐみをわずかに感じる
2点:磨き初めのえぐみを感じる
1点:磨き初めのえぐみをとても感じる
(評価基準)
★:平均3.5点以上
◎:平均3.0点以上3.5点未満
〇:平均2.5点以上3.0未満
△:平均2.0点以上2.5点未満
×:平均2.0点未満
(Rating criteria)
4 points: no harshness at the beginning of polishing is felt 3 points: slight harshness at the beginning of polishing is felt 2 points: the harshness at the beginning of polishing is felt 1 point: the harshness at the beginning of polishing is strongly felt (evaluation criteria)
★: Average 3.5 or more ◎: Average 3.0 or more and less than 3.5 〇: Average 2.5 or more and less than 3.0 △: Average 2.0 or more and less than 2.5 ×: Average 2 Less than 0 points
(A)成分を含むが(B)成分を含まない比較例1及び2では磨きはじめにえぐみが感じられたが、(A)及び(B)成分を含む実施例1~35は、磨きはじめのえぐみが抑えられていた。(A)及び(B)成分のほかにさらに(C)成分を含む実施例10~25、27、29~35は、磨きはじめのえぐみのなさが良好であった。 In Comparative Examples 1 and 2 containing component (A) but not containing component (B), harshness was felt at the beginning of polishing. Acne was suppressed. Examples 10 to 25, 27, and 29 to 35, which further contained component (C) in addition to components (A) and (B), were excellent in lack of harshness at the beginning of polishing.
以下、処方例を示す。 Formulation examples are shown below.
処方例1:洗口剤
(A-1)デキストラナーゼ(単位/g) 20
(B-1)N-エチル-p-メンタン-3-カルボキサミド 0.07
(C)脂肪酸トリグリセリド 0.6
(D-1)濃グリセリン(99.5%、阪本薬品工業製) 残
(D-2)ポリエチレングリコール400 20
(D-3)プロピレングリコール 10
サッカリンナトリウム 0.01
メチルパラベン 0.1
合計 100
(A)/(B)=20000
Formulation Example 1: Mouthwash (A-1) Dextranase (unit/g) 20
(B-1) N-ethyl-p-menthane-3-carboxamide 0.07
(C) Fatty acid triglyceride 0.6
(D-1) Concentrated glycerin (99.5%, manufactured by Sakamoto Yakuhin Kogyo) Balance (D-2) Polyethylene glycol 400 20
(D-3) propylene glycol 10
Saccharin sodium 0.01
Methylparaben 0.1
Total 100
(A)/(B) = 20000
処方例2:洗口剤
(A-1)デキストラナーゼ(単位/g) 20
(B-1)N-エチル-p-メンタン-3-カルボキサミド 0.07
(C)脂肪酸トリグリセリド 0.6
(D-1)濃グリセリン(99.5%、阪本薬品工業製) 残
(D-2)ポリエチレングリコール400 20
(D-3)プロピレングリコール 10
サッカリンナトリウム 0.01
メチルパラベン 0.1
合計 100
(A)/(B)=20000
Formulation Example 2: Mouthwash (A-1) Dextranase (unit/g) 20
(B-1) N-ethyl-p-menthane-3-carboxamide 0.07
(C) Fatty acid triglyceride 0.6
(D-1) Concentrated glycerin (99.5%, manufactured by Sakamoto Yakuhin Kogyo) Balance (D-2) Polyethylene glycol 400 20
(D-3) propylene glycol 10
Saccharin sodium 0.01
Methylparaben 0.1
Total 100
(A)/(B) = 20000
処方例3:洗口剤
(A-1)デキストラナーゼ(単位/g) 20
(B-2)N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド
0.07
(C)脂肪酸トリグリセリド 0.6
(D-1)濃グリセリン(99.5%、阪本薬品工業製) 残
(D-2)ポリエチレングリコール400 30
(D-3)プロピレングリコール 10
サッカリンナトリウム 0.01
メチルパラベン 0.1
合計 100
(A)/(B)=20000
Formulation Example 3: Mouthwash (A-1) Dextranase (unit/g) 20
(B-2) N-(4-cyanomethylphenyl)-p-menthanecarboxamide
0.07
(C) Fatty acid triglyceride 0.6
(D-1) Concentrated glycerin (99.5%, manufactured by Sakamoto Yakuhin Kogyo) Balance (D-2) Polyethylene glycol 400 30
(D-3) propylene glycol 10
Saccharin sodium 0.01
Methylparaben 0.1
Total 100
(A)/(B) = 20000
処方例4:洗口剤
(A-1)デキストラナーゼ(単位/g) 20
(B-3)3-l-メントキシプロパン-1,2-ジオール 0.07
(C)脂肪酸トリグリセリド 0.6
(D-1)濃グリセリン(99.5%、阪本薬品工業製) 残
(D-2)ポリエチレングリコール400 30
(D-3)プロピレングリコール 10
サッカリンナトリウム 0.01
メチルパラベン 0.1
合計 100
(A)/(B)=20000
Formulation Example 4: Mouthwash (A-1) dextranase (unit/g) 20
(B-3) 3-l-menthoxypropane-1,2-diol 0.07
(C) Fatty acid triglyceride 0.6
(D-1) Concentrated glycerin (99.5%, manufactured by Sakamoto Yakuhin Kogyo) Balance (D-2) Polyethylene glycol 400 30
(D-3) propylene glycol 10
Saccharin sodium 0.01
Methylparaben 0.1
Total 100
(A)/(B) = 20000
処方例5:マウススプレー
(A-1)デキストラナーゼ(単位/g) 20
(B-3)3-l-メントキシプロパン-1,2-ジオール 0.02
(C)脂肪酸トリグリセリド 0.6
(D-1)濃グリセリン(99.5%、阪本薬品工業製) 残
(D-2)ポリエチレングリコール400 30
サッカリンナトリウム 0.01
メチルパラベン 0.1
合計 100
(A)/(B)=20000
Formulation Example 5: Mouth Spray (A-1) Dextranase (unit/g) 20
(B-3) 3-l-menthoxypropane-1,2-diol 0.02
(C) Fatty acid triglyceride 0.6
(D-1) Concentrated glycerin (99.5%, manufactured by Sakamoto Yakuhin Kogyo) Balance (D-2) Polyethylene glycol 400 30
Saccharin sodium 0.01
Methylparaben 0.1
Total 100
(A)/(B) = 20000
Claims (8)
(B)成分:N-エチル-p-メンタン-3-カルボキサミド、3-l-メントキシプロパン-1,2-ジオール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、(1R、2S、5R)-5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3カルボキサミド)酢酸エチル、2-イソプロピル-N、2,3-トリメチルブチルアミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、及び、メントングリセロールケタールからなる群より選ばれる少なくとも1種の冷感剤
を含有する非水系口腔用組成物。 (A) component: enzyme, and (B) component: N-ethyl-p-menthane-3-carboxamide, 3-l-menthoxypropane-1,2-diol, N-(4-cyanomethylphenyl)-p - menthanecarboxamide, (1R,2S,5R)-5-methyl-2-propan-2-yl-N-(2-pyridin-2-ylethyl)cyclohexane-1-carboxamide, 3-(p-menthane-3 carboxamide ) Ethyl acetate, 2-isopropyl-N, 2,3-trimethylbutyramide, menthyl lactate, menthyl monosuccinate, isopulegol, and a cooling agent containing at least one cooling agent selected from the group consisting of menthone glycerol ketal A water-based oral composition.
オキシゲナーゼが、ラッカーゼ、ラクトパーオキシダーゼ、又はグルコースオキシダーゼであること、及び、
プロテアーゼが、パパイン、アクチニジン、ブロメライン、又はナットウキナーゼであること
のいずれかを満たす、請求項4に記載の非水系口腔用組成物。 the glucanase is dextranase or mutanase;
the oxygenase is laccase, lactoperoxidase, or glucose oxidase; and
5. The non-aqueous oral composition according to claim 4, wherein the protease is papain, actinidin, bromelain, or nattokinase.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021166581A JP2023057209A (en) | 2021-10-11 | 2021-10-11 | Non-aqueous oral composition |
CN202280062561.7A CN117956976A (en) | 2021-10-11 | 2022-10-07 | Nonaqueous oral composition |
PCT/JP2022/037696 WO2023063269A1 (en) | 2021-10-11 | 2022-10-07 | Nonaqueous composition for oral cavity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021166581A JP2023057209A (en) | 2021-10-11 | 2021-10-11 | Non-aqueous oral composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023057209A true JP2023057209A (en) | 2023-04-21 |
Family
ID=85987726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021166581A Pending JP2023057209A (en) | 2021-10-11 | 2021-10-11 | Non-aqueous oral composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2023057209A (en) |
CN (1) | CN117956976A (en) |
WO (1) | WO2023063269A1 (en) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62422A (en) * | 1985-06-27 | 1987-01-06 | Kenzo Shimomura | Subcutaneous absorption drug |
JP2003055180A (en) * | 2001-08-21 | 2003-02-26 | Lion Corp | Composition for oral cavity |
EP1566167B1 (en) * | 2002-11-07 | 2011-10-12 | Taisho Pharmaceutical Co., Ltd | Base for oral composition and oral composition |
JP2005041787A (en) * | 2003-07-23 | 2005-02-17 | Lion Corp | Dentifrice composition |
JP5765225B2 (en) * | 2009-06-08 | 2015-08-19 | ライオン株式会社 | Oral composition |
JP2019167297A (en) * | 2018-03-22 | 2019-10-03 | ライオン株式会社 | Dentifrice composition |
JP7310357B2 (en) * | 2018-07-06 | 2023-07-19 | ライオン株式会社 | oral composition |
JP7075489B2 (en) * | 2018-07-17 | 2022-05-25 | 日本ゼトック株式会社 | Non-aqueous oral composition |
JP2021031426A (en) * | 2019-08-22 | 2021-03-01 | ライオン株式会社 | Polyhydric alcohol dentifrice composition |
-
2021
- 2021-10-11 JP JP2021166581A patent/JP2023057209A/en active Pending
-
2022
- 2022-10-07 CN CN202280062561.7A patent/CN117956976A/en active Pending
- 2022-10-07 WO PCT/JP2022/037696 patent/WO2023063269A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN117956976A (en) | 2024-04-30 |
WO2023063269A1 (en) | 2023-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5790455B2 (en) | Dentifrice composition | |
JP2016199598A (en) | Compositions for oral cavity | |
JP2011140454A (en) | Composition for oral cavity | |
WO2011055709A1 (en) | Dentifrice composition | |
JP2020011951A (en) | Oral composition | |
JP6471430B2 (en) | Oral composition | |
JPH10501265A (en) | Mouth rinse composition | |
JP6050943B2 (en) | Liquid oral composition for inhibiting stain formation with excellent storage stability | |
JP2011173873A (en) | Composition for oral cavity | |
JP2013151473A (en) | Composition for oral cavity | |
JP5509631B2 (en) | Application gel composition for oral cavity | |
JP5228380B2 (en) | Dentifrice composition | |
WO2023063269A1 (en) | Nonaqueous composition for oral cavity | |
JP7558059B2 (en) | Oral Composition | |
JP2005082488A (en) | Composition for oral cavity and method for masking offensive taste and smell | |
JP6820149B2 (en) | Oral composition | |
JP2005041787A (en) | Dentifrice composition | |
JP2010143842A (en) | Dentifrice composition | |
JP7347916B2 (en) | dentifrice composition | |
JP6435852B2 (en) | Oral composition and method for preventing discoloration of oral composition | |
JP7539829B2 (en) | Oral Composition | |
JP2021031426A (en) | Polyhydric alcohol dentifrice composition | |
JP7567791B2 (en) | Composition for oral cavity and agent for providing massage sensation to gums | |
CN111902125A (en) | Oral composition and bitterness improver for alpha-olefin sulfonate | |
JP2023079019A (en) | oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240412 |